Medical devices, healthcare technology and the business of care
PMA approval · P960013

TENDRIL DX MODEL 1388T & 1388K ENDOCARDIAL PACING LEADS

ABBOTT MEDICAL · Decision date Jun 20, 1997

MEDTECHLEDGER EXPLANATIONP960013

What did the FDA approve?

FDA database entry P960013 records an approval decision dated June 20, 1997, for the Tendril DX Models 1388T and 1388K endocardial, steroid-eluting, screw-in pacing leads and the Ventritex Assure AFS Models 7010T and 7010K endocardial, steroid-eluting screw-in pacing leads. The applicant is listed as Abbott Medical, and the device category is drug-eluting permanent right ventricular or right atrial pacemaker electrodes.

The source statement describes these devices as indicated for use with a compatible pulse generator to provide permanent pacing and sensing in either the atrium or ventricle. This reported purpose is distinct from independent proof of safety or clinical effectiveness. The entry does not identify a supplement type or reason, so no relationship to a prior PMA scope change can be established from the supplied fields.

FDA approval order statement

APPROVAL FOR THE TENDRIL(R) DX MODELS 388T/K ENDOCARDIAL, STEROID ELUTING, SCREW-IN PACING LEADS AND VENTRITEX ASSURE(TM) AFS MODELS 7010T/K ENDOCARDIAL, STERIOID ELUTING SCREW-IN PACING LEADS. THESE DEVICES ARE INDICATED FOR USE IN COMBINATION IWTH A COMPATIBLE PULSE GENERATOR TO PROVIDE PERMANENT PACING AND SENSING IN EITHER THE ATRIUM OR VENTRICLE.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 20, 1997

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960013
Regulatory pathway
Premarket approval application
Product code
NVN
Decision code
APPR
Decision date
Jun 20, 1997
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.

Product code
NVN
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P960013 received

    Application receipt date recorded by FDA.

  2. P960013 · FDA decision

    APPR

  3. P960013/S135 · Related supplement

    Motorized Outer Tubing Cutter for UltiPace Leads

Timeline entries are records held by MedtechLedger for P960013. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960013

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 9, 2026FDA

Explore the linked device profile

Other records with product code NVN

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 16, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA approvalAug 3, 2005FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91335

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records